Yifu He
Yifu He publishes mostly in Pulmonary and Respiratory Medicine, Oncology and Surgery, on topics such as Gastric Cancer Management and Outcomes, Colorectal Cancer Treatments and Studies and Cholangiocarcinoma and Gallbladder Cancer Studies.
- World rank
- #973,198 of 7,710,434 ranked researchers
- Rank in China
- #136,182 of 978,568
- Works
- 136
- Citations
- 4.6k
- Citations per work
- 34.0
What does Yifu He research?
Yifu He's work is mostly in Medicine (57%), Biochemistry, Genetics and Molecular Biology (12%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences7857.4%
- Medicine7857.4%
- Everything else4231.0%
- Life Sciences1611.6%
- 1Pulmonary and Respiratory Medicine21% of their works
- 2Oncology20% of their works
- 3Surgery14% of their works
- 4Molecular Biology8% of their works
- 5Cancer Research4% of their works
- 6Pathology and Forensic Medicine3% of their works
Research topics
- Gastric Cancer Management and Outcomes
- Colorectal Cancer Treatments and Studies
- Cholangiocarcinoma and Gallbladder Cancer Studies
- Lung Cancer Treatments and Mutations
- Cancer Immunotherapy and Biomarkers
- Esophageal Cancer Research and Treatment
- Gastrointestinal Tumor Research and Treatment
- Inflammatory Biomarkers in Disease Prognosis
Which keywords describe Yifu He's research?
The keywords of their largest research topics: Chemotherapy, Endoscopic Resection, Gastric Cancer, Molecular Characterization, Epidemiology, Prognostic Factors, Surgical Management and Cetuximab.
- Sunitinib
- Imatinib Mesylate
- Preoperative Chemoradiotherapy
- PD-1 and PD-L1
- Targeted Therapy
- Tumor Microenvironment
- Biliary Tract Cancer
- Cetuximab
- Prognostic Factors
- Molecular Characterization
- Endoscopic Resection
- Chemotherapy
- Gastric Cancer
- Epidemiology
- Surgical Management
- KRAS Mutations
- Cholangiocarcinoma
- EGFR Mutations
- Immune Checkpoint Blockade
- Esophageal Carcinoma
- Cancer
- Inflammation
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 22 words, with their numbers
- Chemotherapy782 topics
- Endoscopic Resection622 topics
- Gastric Cancer481 topic
- Molecular Characterization481 topic
- Epidemiology392 topics
- Prognostic Factors342 topics
- Surgical Management342 topics
- Cetuximab301 topic
- KRAS Mutations301 topic
- Biliary Tract Cancer251 topic
- Cholangiocarcinoma251 topic
- Tumor Microenvironment252 topics
- EGFR Mutations171 topic
- Targeted Therapy171 topic
- Immune Checkpoint Blockade161 topic
- PD-1 and PD-L1161 topic
- Esophageal Carcinoma141 topic
- Preoperative Chemoradiotherapy141 topic
- Cancer91 topic
- Imatinib Mesylate91 topic
- Inflammation91 topic
- Sunitinib91 topic
Where does Yifu He work?
Yifu He's main affiliation in the publication record is Anhui Provincial Hospital, China.
How many publications and citations does Yifu He have?
OpenAlex counts 136 works and 4,620 citations for Yifu He, an h-index of 25, ranking #973,198 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Yifu He. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.